cbdMD (YCBD) Shares Outstanding (Weighted Average) (2016 - 2025)
cbdMD's (YCBD) quarterly Shares Outstanding (Weighted Average) came in at $5472.0 in Q4 2025, down 99.04% year-on-year from $569008.0 in Q4 2024, and down 7.27% quarter-over-quarter from $5901.0 in Q3 2025.
cbdMD (YCBD) Shares Outstanding (Weighted Average) (2016 - 2025) Analysis & Trends
cbdMD has disclosed Shares Outstanding (Weighted Average) across 10 years of filings, most recently posting $5472.0 for Q4 2025.
- Shares Outstanding (Weighted Average) for Q4 2025 came in at $5472.0, down 99.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $5472.0 (down 99.04% YoY), and the FY2025 annual result was $5901.0, down 4.33% from the prior year.
- Shares Outstanding (Weighted Average) came in at $5472.0 for Q4 2025 at cbdMD, down from $5901.0 in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $57.8 million in Q4 2021 to a low of $5472.0 in Q4 2025.
- The 5-year median for Shares Outstanding (Weighted Average) is $96845.5 (2021), against an average of $6.0 million.
- Across the five-year window, Shares Outstanding (Weighted Average) plunged 99.65% in 2021 and jumped 1031.03% in 2024, its largest moves.
- cbdMD's Shares Outstanding (Weighted Average) stood at $57.8 million in 2021, then plunged by 99.15% to $489917.0 in 2022, then slumped by 89.73% to $50309.0 in 2023, then surged by 1031.03% to $569008.0 in 2024, then slumped by 99.04% to $5472.0 in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $5472.0 (Q4 2025), $5901.0 (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | cbdMD | 3,905.91 | -3.38 Mn | 3.00 Mn | 5,472.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,472.00 |
| Sep 30, 2025 | 5,901.00 |
| Jun 30, 2025 | 2.38 Mn |
| Mar 31, 2025 | 5,901.00 |
| Dec 31, 2024 | 569,008.00 |
| Sep 30, 2024 | 6,168.00 |
| Jun 30, 2024 | 399,496.00 |
| Mar 31, 2024 | 50,309.00 |
| Dec 31, 2023 | 50,309.00 |
| Sep 30, 2023 | 50,309.00 |
| Jun 30, 2023 | 2.38 Mn |
| Mar 31, 2023 | 10,887.00 |
| Dec 31, 2022 | 489,917.00 |
| Sep 30, 2022 | 13,204.00 |
| Jun 30, 2022 | 660,417.00 |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 57.83 Mn |
| Sep 30, 2021 | 14,771.00 |
| Jun 30, 2021 | 143,382.00 |
| Mar 31, 2021 | 52.79 Mn |